Becton Dickinson and Co
NYSE:BDX

Watchlist Manager
Becton Dickinson and Co Logo
Becton Dickinson and Co
NYSE:BDX
Watchlist
Price: 224.25 USD -0.55% Market Closed
Market Cap: 64.8B USD
Have any thoughts about
Becton Dickinson and Co?
Write Note

Intrinsic Value

The intrinsic value of one BDX stock under the Base Case scenario is 292.11 USD. Compared to the current market price of 224.25 USD, Becton Dickinson and Co is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BDX Intrinsic Value
292.11 USD
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Becton Dickinson and Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Becton Dickinson and Co

Provide an overview of the primary business activities
of Becton Dickinson and Co.

What unique competitive advantages
does Becton Dickinson and Co hold over its rivals?

What risks and challenges
does Becton Dickinson and Co face in the near future?

Has there been any significant insider trading activity
in Becton Dickinson and Co recently?

Summarize the latest earnings call
of Becton Dickinson and Co.

What significant events have occurred
in Becton Dickinson and Co over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Becton Dickinson and Co.

Provide P/S
for Becton Dickinson and Co.

Provide P/E
for Becton Dickinson and Co.

Provide P/OCF
for Becton Dickinson and Co.

Provide P/FCFE
for Becton Dickinson and Co.

Provide P/B
for Becton Dickinson and Co.

Provide EV/S
for Becton Dickinson and Co.

Provide EV/GP
for Becton Dickinson and Co.

Provide EV/EBITDA
for Becton Dickinson and Co.

Provide EV/EBIT
for Becton Dickinson and Co.

Provide EV/OCF
for Becton Dickinson and Co.

Provide EV/FCFF
for Becton Dickinson and Co.

Provide EV/IC
for Becton Dickinson and Co.

Show me price targets
for Becton Dickinson and Co made by professional analysts.

What are the Revenue projections
for Becton Dickinson and Co?

How accurate were the past Revenue estimates
for Becton Dickinson and Co?

What are the Net Income projections
for Becton Dickinson and Co?

How accurate were the past Net Income estimates
for Becton Dickinson and Co?

What are the EPS projections
for Becton Dickinson and Co?

How accurate were the past EPS estimates
for Becton Dickinson and Co?

What are the EBIT projections
for Becton Dickinson and Co?

How accurate were the past EBIT estimates
for Becton Dickinson and Co?

Compare the revenue forecasts
for Becton Dickinson and Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Becton Dickinson and Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Becton Dickinson and Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Becton Dickinson and Co compared to its peers.

Compare the P/E ratios
of Becton Dickinson and Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Becton Dickinson and Co with its peers.

Analyze the financial leverage
of Becton Dickinson and Co compared to its main competitors.

Show all profitability ratios
for Becton Dickinson and Co.

Provide ROE
for Becton Dickinson and Co.

Provide ROA
for Becton Dickinson and Co.

Provide ROIC
for Becton Dickinson and Co.

Provide ROCE
for Becton Dickinson and Co.

Provide Gross Margin
for Becton Dickinson and Co.

Provide Operating Margin
for Becton Dickinson and Co.

Provide Net Margin
for Becton Dickinson and Co.

Provide FCF Margin
for Becton Dickinson and Co.

Show all solvency ratios
for Becton Dickinson and Co.

Provide D/E Ratio
for Becton Dickinson and Co.

Provide D/A Ratio
for Becton Dickinson and Co.

Provide Interest Coverage Ratio
for Becton Dickinson and Co.

Provide Altman Z-Score Ratio
for Becton Dickinson and Co.

Provide Quick Ratio
for Becton Dickinson and Co.

Provide Current Ratio
for Becton Dickinson and Co.

Provide Cash Ratio
for Becton Dickinson and Co.

What is the historical Revenue growth
over the last 5 years for Becton Dickinson and Co?

What is the historical Net Income growth
over the last 5 years for Becton Dickinson and Co?

What is the current Free Cash Flow
of Becton Dickinson and Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Becton Dickinson and Co.

Business Breakdown

Becton Dickinson and Co. (BD) is a global leader in the medical technology sector, with a rich history tracing back to its founding in 1897. The company specializes in the development, manufacturing, and distribution of a wide array of medical devices, instrument systems, and reagents that are essential in hospitals and laboratories. BD's products play a pivotal role in improving patient outcomes by enhancing the accuracy of diagnostics and facilitating efficient pharmaceutical delivery. With a commitment to innovation, BD invests significantly in research and development, ensuring it remains at the forefront of advanced technology in healthcare, which resonates well with investors seeking s...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Becton Dickinson and Co

Current Assets 10.5B
Cash & Short-Term Investments 2.2B
Receivables 3B
Other Current Assets 5.3B
Non-Current Assets 46.8B
PP&E 6.8B
Intangibles 37.4B
Other Non-Current Assets 2.6B
Current Liabilities 8.9B
Other Current Liabilities 8.9B
Non-Current Liabilities 22.4B
Long-Term Debt 17.9B
Other Non-Current Liabilities 4.5B
Efficiency

Earnings Waterfall
Becton Dickinson and Co

Revenue
20.2B USD
Cost of Revenue
-11B USD
Gross Profit
9.2B USD
Operating Expenses
-6.3B USD
Operating Income
2.9B USD
Other Expenses
-1.2B USD
Net Income
1.7B USD

Free Cash Flow Analysis
Becton Dickinson and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Becton Dickinson (BD) reported solid Q4 results with 7.4% revenue growth and expanded margins. For FY 2025, the company expects total revenues between $21.9 billion and $22.1 billion, reflecting 8.8% to 9.3% currency-neutral growth. Key drivers include an anticipated 4% to 4.5% organic growth, boosted by the Advanced Patient Monitoring acquisition. BD targets a 10% increase in adjusted EPS, aiming to expand adjusted operating margins by 100 basis points. While navigating market challenges in China, BD remains optimistic about long-term growth, maintaining a focus on innovation and operational excellence.

What is Earnings Call?
Fundamental Scores

BDX Profitability Score
Profitability Due Diligence

Becton Dickinson and Co's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive Operating Income
52/100
Profitability
Score

Becton Dickinson and Co's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

BDX Solvency Score
Solvency Due Diligence

Becton Dickinson and Co's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
47/100
Solvency
Score

Becton Dickinson and Co's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDX Price Targets Summary
Becton Dickinson and Co

Wall Street analysts forecast BDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDX is 283.5 USD with a low forecast of 252.48 USD and a high forecast of 340.33 USD.

Lowest
Price Target
252.48 USD
13% Upside
Average
Price Target
283.5 USD
26% Upside
Highest
Price Target
340.33 USD
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BDX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

BDX News

Other Videos

Profile

Becton Dickinson and Co Logo
Becton Dickinson and Co

Country

United States of America

Industry

Health Care

Market Cap

64.8B USD

Dividend Yield

1.69%

Description

Becton, Dickinson & Co. is a medical technology company. The company is headquartered in Franklin Lakes, New Jersey and currently employs 75,000 full-time employees. The firm operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Contact

NEW JERSEY
Franklin Lakes
One Becton Drive
+12018476800.0
www.bd.com

IPO

1963-09-25

Employees

75 000

Officers

President, CEO & Chairman
Mr. Thomas E. Polen Jr.
Executive VP & CFO
Mr. Christopher J. DelOrefice
Executive VP & Chief People Officer
Ms. Shana Carol Neal
Executive VP & President of Medical segment
Mr. Michael Garrison
Senior VP, Controller & Chief Accounting Officer
Mr. Thomas J. Spoerel
Executive VP & Chief Technology Officer
Ms. Elizabeth McCombs
Show More
Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.
Executive VP of Technology & Global Services and Chief Information Officer
Ms. Denise Russell Fleming
Head of Investor Relations
Mr. Greg Rodetis
Executive VP & General Counsel
Ms. Michelle Quinn
Show Less

See Also

Discover More
What is the Intrinsic Value of one BDX stock?

The intrinsic value of one BDX stock under the Base Case scenario is 292.11 USD.

Is BDX stock undervalued or overvalued?

Compared to the current market price of 224.25 USD, Becton Dickinson and Co is Undervalued by 23%.

Back to Top